본문 바로가기
  • Home

Why Do Normal-Weight Individuals Seek GLP-1 Weight-Loss Injections (Wegovy and Mounjaro)?: Focusing on the Psychological Drivers of Weight Bias Internalization

  • Health Communication Research
  • 2026, 25(1), pp.1~46
  • DOI : 10.24172/hcr.2026.25.1.1
  • Publisher : Korea Health Communication Association
  • Research Area : Social Science > Journalism and Broadcasting > Communication
  • Received : February 13, 2026
  • Accepted : April 21, 2026
  • Published : April 30, 2026

Park Woo-Seung 1 Jaehee Cho 1

1서강대학교

Accredited

ABSTRACT

The off-label use of GLP-1 weight-loss medications (e.g., Wegovy, Mounjaro) among normal-weight adults for aesthetic purposes is a growing public health concern. This study investigates the psychological mechanisms linking Weight Bias Internalization (WBI) to the intention to use these injections. Integrating the Situational Theory of Problem Solving (STOPS) and Protection Motivation Theory (PMT), structural equation modeling (SEM) was applied to a sample of normal-weight adults. Results revealed that WBI sequentially influences medication intention through situational recognition and coping appraisal. Problem recognition created an ambivalent path, simultaneously increasing perceived response efficacy and response costs. Conversely, involvement recognition strengthened medication intention by significantly lowering perceived response costs. Furthermore, appearance orientation moderated the WBI-response cost relationship; higher appearance orientation heightened perceived costs, acting as a protective mechanism against misuse. These findings elucidate how internalized weight bias translates into specific drug adoption, offering crucial insights for mitigating medication misuse.

Citation status

* References for papers published after 2024 are currently being built.